OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

DAIICHI SANKYO CO. LTD/  JP3475350009  /

Frankfurt
2024-05-14  8:02:33 AM Chg. +0.8700 Volume Bid12:58:23 PM Ask12:58:23 PM Market Capitalization Dividend Y. P/E Ratio
32.6600EUR +2.74% 30
Turnover: 979.8000		 31.5900Bid Size: 180 32.5400Ask Size: 180 61.25 bill.EUR - -
GlobeNewswire 05-07 Esperion Reports First Quarter 2024 Financial Results
GlobeNewswire 05-02 Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 04-29 Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Eva...
GlobeNewswire 03-29 Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
GlobeNewswire 03-22 CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose ...
GlobeNewswire 02-27 Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 02-15 Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 01-03 Esperion and Daiichi Sankyo Europe Announce $125 Million Amendment to Their Collaboration, Including...
GlobeNewswire 2023-11-29 INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breas...
GlobeNewswire 2023-11-28 Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
GlobeNewswire 2023-11-07 Esperion Reports Third Quarter 2023 Financial Results
GlobeNewswire 2023-11-02 Ultragenyx Reports Third Quarter 2023 Financial Results and Corporate Update
GlobeNewswire 2023-11-02 vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer
TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs
GlobeNewswire 2023-10-02 Prevent Cancer Foundation raises more than $2 million for cancer prevention and early detection at a...
GlobeNewswire 2023-09-27 CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal includ...
GlobeNewswire 2023-09-13 Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Developm...
GlobeNewswire 2023-09-06 Jordanian royalty to grace Prevent Cancer Foundation 29th Annual Gala
GlobeNewswire 2023-08-31 RAIN Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in...
GlobeNewswire 2022-03-24 Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform
GlobeNewswire 2022-03-07 Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
GlobeNewswire 2022-03-03 AIM ImmunoTech Appoints Robert Dickey, IV as Chief Financial Officer
GlobeNewswire 2022-03-01 Fight Colorectal Cancer is demanding MORE from Congress this March
GlobeNewswire 2022-02-22 Sanofi’s Board of Directors proposes the appointment of Carole Ferrand, Emile Voest and Antoine Yver...